Taking SaMDs to market in the US
The number of software as a medical device (SaMD) products has grown over the past few years. While they have brought significant advancements to the medtech industry, their unique features and broad applications have led to confusion about the definition of SaMD and how to effectively obtain market clearance for them.
Join Principal at MDQR Solutions, Prabhu Raghavan, and Rimsys Co-Founder and Chief Solutions Officer, Brad Ryba, as they discuss the various categories and market pathways for SaMDs in the United States. Attendees will leave the discussion with a strong understanding of SaMD, how it differs from traditional medical devices, and key factors to consider when submitting a SaMD for approval.